Know What's Happening in Healthcare

Today's Healthcare Pulse

Abridge teams with Eli Lilly and Nvidia to expand AI scribe platform

Abridge announced a strategic investment from Eli Lilly and a partnership with Nvidia to build a foundation model for clinical conversations. The collaboration aims to broaden Abridge’s AI‑scribe services across more health systems and integrate with payers. The company already supports over 300 health systems.

WHO Expands COVID Contact Definition to Shared Enclosed Spaces
SocialMay 10, 2026

WHO Expands COVID Contact Definition to Shared Enclosed Spaces

Good update from WHO, with a very important clarification of what a “contact” is: —-> “Exposure in enclosed or shared spaces (e.g. multiple days on same ship, aircraft/conveyance seating proximity, etc.)” I don’t love the “multiple days” in the example bc it’s inconsistent...

By Joseph G. Allen
AMH Measures Egg Count, Not Pregnancy Potential
SocialMay 10, 2026

AMH Measures Egg Count, Not Pregnancy Potential

AMH does not predict whether you can get pregnant naturally. It predicts how many eggs your ovaries will produce on stimulation drugs. That is it. Fertility clinics use it to scare women into IVF because it is a number that...

By Preethi Kasireddy
With Commissioner Under Pressure, F.D.A. Opens Door to Flavored Vapes
NewsMay 10, 2026

With Commissioner Under Pressure, F.D.A. Opens Door to Flavored Vapes

The Trump administration released an FDA guidance that would permit flavored e‑cigarettes to be sold in mainstream retail outlets, effectively rolling back a year of tightened tobacco‑control measures. The move comes amid reports that President Trump signed a plan to...

By New York Times – Science
U.S. Federal Initiative Targets Psychiatric Overprescribing, Boosts Holistic Care
NewsMay 10, 2026

U.S. Federal Initiative Targets Psychiatric Overprescribing, Boosts Holistic Care

U.S. federal health officials unveiled an initiative to curb the overprescription of psychiatric drugs and shift treatment toward holistic, interdisciplinary care. The plan emphasizes rigorous deprescribing protocols and the integration of nutrition, therapy and lifestyle interventions.

By Pulse
Australia’s TGA Issues Interim Decision to Tighten Vitamin B6 Supplement Rules
NewsMay 10, 2026

Australia’s TGA Issues Interim Decision to Tighten Vitamin B6 Supplement Rules

The Therapeutic Goods Administration (TGA) released an interim decision to review and potentially tighten regulations on high‑dose Vitamin B6 (pyridoxine) supplements in Australia. The move follows rising safety concerns over peripheral neuropathy linked to prolonged excessive intake. The decision now...

By Pulse
New Zealand Study Shows Low‑Income Mothers Sacrifice Their Diets to Feed Infants
NewsMay 10, 2026

New Zealand Study Shows Low‑Income Mothers Sacrifice Their Diets to Feed Infants

A University of Otago‑led study finds low‑income New Zealand mothers routinely forgo nutritious meals to ensure their infants are fed, as households with children under five reporting food scarcity climbed to 20% in 2024. Researchers call for systemic, family‑centred policies to...

By Pulse
Evidence-Based Lifestyle Guide for Breast Cancer Survivors
SocialMay 10, 2026

Evidence-Based Lifestyle Guide for Breast Cancer Survivors

We are thrilled to provide this resource for people who are looking for a path through breast cancer and beyond. 💗 PAVING the Path to Wellness with Evidence-Based Lifestyle Medicine Tools for Cancer Survivorship is a fabulous resource for those newly...

By Beth Frates, MD
Garlic-Derived S1PC Boosts Anti‑Aging Pathway in Fat Cells, Improves Mouse Muscle Strength
NewsMay 10, 2026

Garlic-Derived S1PC Boosts Anti‑Aging Pathway in Fat Cells, Improves Mouse Muscle Strength

Researchers at Washington University and Japanese partners identified S‑1‑propenyl‑L‑cysteine (S1PC) in aged garlic extract as a trigger for a fat‑brain‑muscle signaling cascade that raises eNAMPT and NAD+ levels. In eight‑month mouse trials, daily S1PC improved muscle force, while a single...

By Pulse
FDA Expands Vyvgart Approval to All Adult Myasthenia Gravis Types
NewsMay 10, 2026

FDA Expands Vyvgart Approval to All Adult Myasthenia Gravis Types

The U.S. FDA approved a label expansion for Argenx's Vyvgart (efgartigimod) and Vyvgart Hytrulo, now covering all four adult generalized myasthenia gravis (gMG) serotypes. The decision is based on the ADAPT SERON Phase 3 trial, which showed a 3.35‑point improvement in...

By Pulse
Quebec Launches $2.5 B Digital Health Record Pilot, Costs Surge to $400 M
NewsMay 10, 2026

Quebec Launches $2.5 B Digital Health Record Pilot, Costs Surge to $400 M

Quebec's public health agency Santé Québec rolled out a pilot of the Epic‑based Digital Health Record (DHR) system in two regional health authorities, with the pilot budgeted at $400 million and total provincewide costs now estimated at $2.5 billion. Officials tout a...

By Pulse
California Governor Race Puts Single‑Payer Health Care on the Spotlight
NewsMay 10, 2026

California Governor Race Puts Single‑Payer Health Care on the Spotlight

Democratic hopeful Katie Porter is pushing a single‑payer health system while rivals such as Xavier Becerra and Tom Steyer also back the idea. The race has turned into a debate over how to fund universal coverage, with fundraising gaps and...

By Pulse
Engineered Nanoparticles Tune Cell Density to Accelerate Tissue Repair
NewsMay 10, 2026

Engineered Nanoparticles Tune Cell Density to Accelerate Tissue Repair

Researchers led by Park, Im and Jeong have unveiled a nanoparticle platform that precisely modulates cell density, enhancing cell‑to‑cell and cell‑to‑substrate adhesion and accelerating tissue repair. The work, published in Nature Communications, demonstrates in vitro and in vivo efficacy and...

By Pulse
EDAP TMS Posts Record Q1 Revenue as Robotic HIFU Sales Surge 78%
NewsMay 10, 2026

EDAP TMS Posts Record Q1 Revenue as Robotic HIFU Sales Surge 78%

EDAP TMS SA announced Q1 2026 revenue of $17.8 million, up 25% year‑over‑year, powered by a 78% surge in its Focal One robotic HIFU system sales. The French‑based medical‑robotics firm guided core HIFU revenue of $50‑$54 million for the full year, underscoring...

By Pulse
FDA Launches ‘Plausible Mechanism Pathway’ to Accelerate Ultra‑Rare Gene Therapies
NewsMay 10, 2026

FDA Launches ‘Plausible Mechanism Pathway’ to Accelerate Ultra‑Rare Gene Therapies

The U.S. Food and Drug Administration announced a new “plausible mechanism pathway” that lets developers deliver patient‑specific gene therapies for ultra‑rare disorders without traditional large‑scale trials. The move promises faster access but has ignited a safety‑versus‑speed debate among ethicists and...

By Pulse
Conn. Firefighter with End-Stage Kidney Failure Finds Donor Match
NewsMay 10, 2026

Conn. Firefighter with End-Stage Kidney Failure Finds Donor Match

Derby, Conn., volunteer firefighter Chris “CJ” Matto, 33, was recently matched with a kidney donor after being diagnosed with end‑stage kidney disease. The Shelton Fire Department announced the match and a June 6 car‑wash fundraiser to offset medical expenses for Matto...

By FireRescue1 – News
W.Va. Congresswoman Honored for Rural EMS Advocacy
NewsMay 10, 2026

W.Va. Congresswoman Honored for Rural EMS Advocacy

U.S. Rep. Carol Miller was honored as one of the American Ambulance Association’s Person of the Year for her advocacy on rural emergency medical services. The award highlights her work on ambulance reimbursement, treatment‑in‑place payment models, and the PEAKS Act,...

By EMS1 – News
Mental Illness Is Pregnancy’s No 1 Complication. It’s Time to Support Those Who Suffer From It | Edna Lekgabe
NewsMay 10, 2026

Mental Illness Is Pregnancy’s No 1 Complication. It’s Time to Support Those Who Suffer From It | Edna Lekgabe

Perinatal mental illness affects roughly one in five women from conception through the first year after birth, making it the most common complication of pregnancy. Despite its prevalence, systematic screening and treatment pathways lag behind those for physical conditions such...

By The Guardian — Opinion (Comment is free)
Assisted Suicide Advocate Grilled over Mental Illness Expansion
BlogMay 10, 2026

Assisted Suicide Advocate Grilled over Mental Illness Expansion

Helen Long, chief executive of Dying with Dignity Canada, testified before the Special Joint Committee on Medical Assistance in Dying, urging an expansion that would let Canadians whose sole condition is a mental illness access MAiD. She claimed roughly 80%...

By The Counter Signal
Evaluating the Effectiveness and Safety of Digitalis Glycosides in Treating Heart Failure
NewsMay 10, 2026

Evaluating the Effectiveness and Safety of Digitalis Glycosides in Treating Heart Failure

A JAMA‑published trial presented at the ESC Heart Failure 2026 Congress found that adding digitalis glycosides to standard therapy lowered the combined risk of cardiovascular death and first worsening heart‑failure event in patients with HFmrEF and HFrEF. The reduction was...

By Bioengineer.org
When a One-Time Rental Sale Triggers an IRMAA Surprise
BlogMay 10, 2026

When a One-Time Rental Sale Triggers an IRMAA Surprise

A one‑time capital gain from selling a rental property can push a retiree’s Modified Adjusted Gross Income into a higher IRMAA bracket, raising Medicare premiums two years later. IRMAA calculations rely on a two‑year income lookback, so the spike may...

By Humbledollar
States Are Advancing Homecare’s Next Big Step — Paying Caregivers for Skill, Not Just Time
NewsMay 10, 2026

States Are Advancing Homecare’s Next Big Step — Paying Caregivers for Skill, Not Just Time

States are moving homecare reimbursement from time‑based to skill‑based rates. New York, Washington and Oregon have introduced mandatory training and certification standards, laying groundwork for tiered Medicaid payments. Providers already offer specialized training, but current fee‑for‑service models pay caregivers the...

By MedCity News
Mothers Need Real Healthcare, Not Just Flowers
SocialMay 10, 2026

Mothers Need Real Healthcare, Not Just Flowers

Mothers deserve more than flowers today. They deserve doctors who take their pain seriously, hormones that are managed properly through every decade, and healthcare that doesn’t treat their symptoms as inconveniences. Happy Mother’s Day ❤️

By Jordan Emont MD MPH MSCP | Menopause and Women’s Health
GLP-1s, Specialty Spend, and a 9% Cost Surge: Why Employers Must Rethink Primary Care Now
NewsMay 10, 2026

GLP-1s, Specialty Spend, and a 9% Cost Surge: Why Employers Must Rethink Primary Care Now

Employers face a projected 9% rise in health‑care costs for 2026, driven largely by soaring GLP‑1 and other specialty drug spend and the persistent burden of chronic disease. The prevailing volume‑based primary‑care model limits coordination, leading to higher pharmacy utilization...

By MedCity News
GLP‑1 Weight‑Loss Drugs Spark ‘Beauty Premium’ and Shrink Grocery Baskets
NewsMay 10, 2026

GLP‑1 Weight‑Loss Drugs Spark ‘Beauty Premium’ and Shrink Grocery Baskets

GLP‑1 receptor agonists such as semaglutide and tirzepatide are driving a measurable shift in U.S. consumer spending: shoppers are buying fewer high‑calorie bulk items while spending roughly 30% more on beauty products. The trend, highlighted in a new market‑impact analysis,...

By Pulse
Surge in Single Women Opting for Motherhood Highlights Shifting Family Norms
NewsMay 10, 2026

Surge in Single Women Opting for Motherhood Highlights Shifting Family Norms

NPR's Pallavi Gogoi reports that more than 60 women across the United States are deliberately choosing to become mothers without a partner. The trend signals a cultural shift that challenges traditional family structures and raises new questions for policymakers and...

By Pulse
GI Partners Launches Rose BioSolutions After Acquiring Charles River Labs' CDMO and Cell Solutions
NewsMay 10, 2026

GI Partners Launches Rose BioSolutions After Acquiring Charles River Labs' CDMO and Cell Solutions

GI Partners has completed the purchase of Charles River Laboratories' Contract Development and Manufacturing Organization (CDMO) and Cell Solutions businesses, creating the standalone company Rose BioSolutions. The new firm will offer integrated cell and gene therapy services across four U.S....

By Pulse
Novo's Oral Wegovy Snags 65% of New U.S. Prescriptions, Challenging Lilly's Foundayo
NewsMay 10, 2026

Novo's Oral Wegovy Snags 65% of New U.S. Prescriptions, Challenging Lilly's Foundayo

Novo Nordisk reported 1.3 million oral Wegovy prescriptions in Q1, giving it 65% of new U.S. weight‑loss drug orders. Eli Lilly’s oral GLP‑1, Foundayo, has treated just over 20,000 patients, underscoring a fierce rivalry in a market projected to near $100 bn by...

By Pulse
Samsung Galaxy Watch Predicts Fainting Episodes with 84.6% Accuracy in Clinical Study
NewsMay 10, 2026

Samsung Galaxy Watch Predicts Fainting Episodes with 84.6% Accuracy in Clinical Study

Samsung announced that its Galaxy Watch 6 accurately predicted vasovagal syncope in a clinical trial of 132 patients, achieving 84.6% accuracy, 90% sensitivity and 64% specificity. Experts warn that real‑world false‑positive alerts could undermine the technology’s usefulness.

By Pulse
Pennsylvania Sues Character.AI Over Chatbot Impersonation of Licensed Doctors
NewsMay 10, 2026

Pennsylvania Sues Character.AI Over Chatbot Impersonation of Licensed Doctors

The Commonwealth of Pennsylvania has filed a lawsuit against AI firm Character.AI, alleging that its chatbots falsely present themselves as licensed physicians and dispense medical advice. The state seeks a court order to halt the practice, arguing it violates medical...

By Pulse
Why We’re Still Finding Cancer Too Late
NewsMay 10, 2026

Why We’re Still Finding Cancer Too Late

The article argues that cancer is still diagnosed too late because standard screening programs miss the majority of cases and fail to account for individual risk factors such as genetics, family history, and ethnicity. It highlights that 40% of people...

By MedCity News
NIRSense Teams with US Army Pacific to Deploy Portable Tissue‑Oxygenation Monitors at Balikatan‑26
NewsMay 10, 2026

NIRSense Teams with US Army Pacific to Deploy Portable Tissue‑Oxygenation Monitors at Balikatan‑26

NIRSense, Inc. joined the US Army Pacific’s 18th Theater Medical Command at the Balikatan‑26 exercise to field portable tissue‑oxygen saturation monitors. The partnership aims to give combat medics real‑time perfusion data, expanding beyond traditional vital signs for faster triage and...

By Pulse
Senseonics Posts $11.7M Q1 Revenue, Lifts 2026 Guidance After $92M Equity Raise
NewsMay 10, 2026

Senseonics Posts $11.7M Q1 Revenue, Lifts 2026 Guidance After $92M Equity Raise

Senseonics announced Q1 2026 revenue of $11.7 million, an 85% year‑over‑year increase, and disclosed a $92 million public equity offering alongside a $20 million draw on its debt facility. The company raised its full‑year revenue guidance to $60‑64 million and outlined margin and...

By Pulse
U.S. Airlifts 17 Americans From Hantavirus-Stricken Cruise Ship to Nebraska Quarantine
NewsMay 10, 2026

U.S. Airlifts 17 Americans From Hantavirus-Stricken Cruise Ship to Nebraska Quarantine

The U.S. government is deploying a CDC‑chartered aircraft to airlift 17 American passengers from the MV Hondius cruise ship after a hantavirus outbreak killed three and infected five others. The evacuees will be quarantined at the University of Nebraska Medical...

By Pulse
Nanoparticle Formulation Erases 60% of Alzheimer Plaques and Restores Memory in Mice
NewsMay 10, 2026

Nanoparticle Formulation Erases 60% of Alzheimer Plaques and Restores Memory in Mice

A collaborative team from Spain and China demonstrated that a specially engineered nanoparticle can eliminate nearly 60% of amyloid‑beta plaques and fully restore memory in Alzheimer’s‑model mice in under an hour. The breakthrough, published in Nature Nanotechnology, targets the blood‑brain...

By Pulse
Cytokinetics Stock Overpriced Amid Strong Aficamten Data
SocialMay 10, 2026

Cytokinetics Stock Overpriced Amid Strong Aficamten Data

Aficamten’s clinical data is strong, but Cytokinetics’ stock price already reflects peak sales. With competition from Camzyos and launch risks ahead, the risk/reward looks skewed at current levels. Biotech

By periodtrader
Gilead’s $11.5B Bet: What Two Companies Saw in One Week
BlogMay 10, 2026

Gilead’s $11.5B Bet: What Two Companies Saw in One Week

Gilead Sciences disclosed $11.5 billion in acquisition charges for three deals, notably Ouro Medicines and Tubulis, on May 7, 2026. In the same week UCB paid $2.2 billion for Candid Therapeutics, a company with an almost identical dual‑target autoimmune platform. Both firms are betting...

By The Billion Dollar Blindspot
Private Equity Drives Majority of Indian Hospital Revenue
SocialMay 10, 2026

Private Equity Drives Majority of Indian Hospital Revenue

WHO CONTROLS HEALTHCARE IN INDIA 🇮🇳 Apollo Hospitals - 43% Average revenue per bed ~ 61000 (Vanguard, GQG, Govt of Singapore) Max Healthcare - 45% Average revenue per bed ~ 78000 (KKR, Partners Group) Healthcare Global - 60% Average revenue per bed ~ 46000 (CVC Capital) Fortis Healthcare -...

By twistie_bites
A&E Is Not Failing: It Is Being Forced to Absorb the Failure of the Rest of the NHS
NewsMay 10, 2026

A&E Is Not Failing: It Is Being Forced to Absorb the Failure of the Rest of the NHS

A recent BMJ letter highlights that 13,386 patients waited over three days in England’s A&E departments in 2025, and nearly half a million spent at least 24 hours in Type 1 emergency rooms. The author argues that rising A&E attendances (15% increase...

By BMJ (Latest)
N.C. County Moves to Keep FirstHealth as EMS Provider
NewsMay 10, 2026

N.C. County Moves to Keep FirstHealth as EMS Provider

Lee County commissioners voted Monday to reopen negotiations with FirstHealth of the Carolinas to retain its ambulance service after the MedEx deal fell apart. FirstHealth, the county’s EMS provider since 2021, was originally passed over in favor of MedEx, which...

By EMS1 – News
Is Testosterone Therapy Safe and Effective? What We Know
NewsMay 10, 2026

Is Testosterone Therapy Safe and Effective? What We Know

A December FDA expert panel advocated expanding testosterone therapy beyond classic hypogonadism, branding it a multibillion‑dollar preventive‑care opportunity. Recent evidence, notably the 5,200‑patient TRAVERSE trial, found no rise in cardiovascular events among high‑risk men receiving therapeutic doses. However, high‑dose use—often...

By Scientific American – Mind
Marty Makary Set the Conditions for His Own Downfall
NewsMay 10, 2026

Marty Makary Set the Conditions for His Own Downfall

Marty Makary, the FDA commissioner appointed by President Biden, is under fire from vaping advocates, pro‑life groups, industry, and former agency officials. Critics allege he politicized the new National Priority Voucher program, overruled career staff on abortion‑pill safety and COVID‑vaccine...

By The Atlantic (Health)
Policy-Driven Pay Gaps Push Doctors Into Hospitals, Lengthening Wait Times
SocialMay 10, 2026

Policy-Driven Pay Gaps Push Doctors Into Hospitals, Lengthening Wait Times

Fifteen years ago, 75 percent of US physicians were in private practice. Today, around 25 percent are. That is not market evolution. That is a policy outcome. Hospitals are paid 2 to 3 times more than independent practices for the same office...

By Kevin Pho, MD
Gene Editing Has the Science Figured Out and Now Needs an Entire Stack of New Business Models, Reimbursement Mechanics, and...
BlogMay 10, 2026

Gene Editing Has the Science Figured Out and Now Needs an Entire Stack of New Business Models, Reimbursement Mechanics, and...

Gene editing has moved from scientific proof‑of‑concept to commercial reality, highlighted by Vertex's CASGEVY therapy earning $43 million in Q1 2026 and treating over 500 patients at a $2.2 million list price. While the science is solid, the therapy’s multi‑step delivery—spanning screening, cell...

By Thoughts on Healthcare Markets & Tech
UK Hospitals Often Lack Weekend Doctors, Raising Cut Concerns
SocialMay 10, 2026

UK Hospitals Often Lack Weekend Doctors, Raising Cut Concerns

My mum has been in two hospitals (in the UK) over the last 28 days and never seen a doctor at the weekend. Is this normal? Is it down to cuts?

By Sarah Stiffin
Longevity Hype Ignores Limited Healthspan Evidence
SocialMay 10, 2026

Longevity Hype Ignores Limited Healthspan Evidence

Why is there such obsession with extending lifespan when the bigger issue is that average healthspan is 65 years and there are no data (except in super-centenarians) that longer lifespan = longer healthspan (known as compression of morbidity)? https://t.co/w33aRn71cn

By Eric Topol
Public Health Should Inform, Not Dictate Emotions
SocialMay 10, 2026

Public Health Should Inform, Not Dictate Emotions

One outbreak and the entire “sane” side of public health resorted back to the paternalism of telling us not to worry or “panic”, “this isn’t Covid”, etc. They didn’t learn a thing. We didn’t appoint them to be our therapists or...

By Zeynep Tufekci
Cancer Treatments Advance, but Response Feedback Still Lags Months
SocialMay 10, 2026

Cancer Treatments Advance, but Response Feedback Still Lags Months

#Cancer therapies have gotten dramatically better Feedback loop on whether the one you're on is working hasn't 3-6 mos is still the wait & for too many patients that gap costs time they don't have @PittHexAI @PittTweet @MIT_Healthcare @NineDiagnostics https://t.co/bAfjSd7UQE

By Freddy T. Nguyen, MD, PhD
Universal Label Masks Healthcare Rationing, Not a Solution
SocialMay 10, 2026

Universal Label Masks Healthcare Rationing, Not a Solution

“Pretending the rest of the world solved healthcare because they slapped the word “universal” on a rationing scheme is not analysis.”

By Cliff Asness
Make Childbearing Affordable and Safe, Not Coercive
SocialMay 10, 2026

Make Childbearing Affordable and Safe, Not Coercive

Happy Mothers’ Day. In the face of a silver tsunami, we need more people to have kids. We should consider policies that makes that an affordable option that’s safer for women, versus one that coerces people into it.

By Christina Farr